Investigating developmental delay in South Africa: A pragmatic approach

Global developmental delay and intellectual disability are common disorders in every population, with a prevalence of 1 - 5%. Although a specific cause is not always immediately identifiable, for many affected people the aetiology is genetic or the result of secondary insult to the developing brain....

Full description

Bibliographic Details
Main Authors: K Fieggen, L Lambie, K Donald
Format: Article
Language:English
Published: South African Medical Association 2019-04-01
Series:South African Medical Journal
Online Access:http://www.samj.org.za/index.php/samj/article/download/12588/8800
_version_ 1797333108944535552
author K Fieggen
L Lambie
K Donald
author_facet K Fieggen
L Lambie
K Donald
author_sort K Fieggen
collection DOAJ
description Global developmental delay and intellectual disability are common disorders in every population, with a prevalence of 1 - 5%. Although a specific cause is not always immediately identifiable, for many affected people the aetiology is genetic or the result of secondary insult to the developing brain. Investigating children with intellectual developmental disorders (IDD) may be a significant challenge, especially in resource-limited settings. Comprehensive clinical evaluation is the first step and frequently determines the direction of further investigations. Hearing and vision screening and thyroid function tests should be performed in most patients. Children with neurological findings should undergo brain imaging, and careful consideration should be given to potential metabolic disorders in all children with IDD, a number of whom are amenable to treatment. Most children in whom a specific direction is not suggested after history-taking and examination, should be tested for chromosomal abnormalities, ideally with chromosomal microarray, which has a diagnostic detection rate of 8 - 20% in IDD. Additional tests may be indicated in particular settings, including broad-based testing for single-gene disorders, such as next-generation sequencing gene panels or exome analysis. All genetic testing has the potential of finding variants of uncertain significance, particularly when there are limited population data, such as in Africa. Making a specific diagnosis in IDD is of benefit to patients, their families and society. Therefore, a rational approach to investigating this group of patients is essential to maximise the health benefit in a cost-effective way.
first_indexed 2024-03-08T07:59:04Z
format Article
id doaj.art-c7aa4e4402dd4376b7227cb635e4cd01
institution Directory Open Access Journal
issn 0256-9574
2078-5135
language English
last_indexed 2024-03-08T07:59:04Z
publishDate 2019-04-01
publisher South African Medical Association
record_format Article
series South African Medical Journal
spelling doaj.art-c7aa4e4402dd4376b7227cb635e4cd012024-02-02T13:04:42ZengSouth African Medical AssociationSouth African Medical Journal0256-95742078-51352019-04-01109421021310.7196/SAMJ.2019.v109i4.13991Investigating developmental delay in South Africa: A pragmatic approachK FieggenL LambieK DonaldGlobal developmental delay and intellectual disability are common disorders in every population, with a prevalence of 1 - 5%. Although a specific cause is not always immediately identifiable, for many affected people the aetiology is genetic or the result of secondary insult to the developing brain. Investigating children with intellectual developmental disorders (IDD) may be a significant challenge, especially in resource-limited settings. Comprehensive clinical evaluation is the first step and frequently determines the direction of further investigations. Hearing and vision screening and thyroid function tests should be performed in most patients. Children with neurological findings should undergo brain imaging, and careful consideration should be given to potential metabolic disorders in all children with IDD, a number of whom are amenable to treatment. Most children in whom a specific direction is not suggested after history-taking and examination, should be tested for chromosomal abnormalities, ideally with chromosomal microarray, which has a diagnostic detection rate of 8 - 20% in IDD. Additional tests may be indicated in particular settings, including broad-based testing for single-gene disorders, such as next-generation sequencing gene panels or exome analysis. All genetic testing has the potential of finding variants of uncertain significance, particularly when there are limited population data, such as in Africa. Making a specific diagnosis in IDD is of benefit to patients, their families and society. Therefore, a rational approach to investigating this group of patients is essential to maximise the health benefit in a cost-effective way.http://www.samj.org.za/index.php/samj/article/download/12588/8800
spellingShingle K Fieggen
L Lambie
K Donald
Investigating developmental delay in South Africa: A pragmatic approach
South African Medical Journal
title Investigating developmental delay in South Africa: A pragmatic approach
title_full Investigating developmental delay in South Africa: A pragmatic approach
title_fullStr Investigating developmental delay in South Africa: A pragmatic approach
title_full_unstemmed Investigating developmental delay in South Africa: A pragmatic approach
title_short Investigating developmental delay in South Africa: A pragmatic approach
title_sort investigating developmental delay in south africa a pragmatic approach
url http://www.samj.org.za/index.php/samj/article/download/12588/8800
work_keys_str_mv AT kfieggen investigatingdevelopmentaldelayinsouthafricaapragmaticapproach
AT llambie investigatingdevelopmentaldelayinsouthafricaapragmaticapproach
AT kdonald investigatingdevelopmentaldelayinsouthafricaapragmaticapproach